<div class="article">
	<h3>Business Brief -- Atrix Laboratories Inc.:
   Company Files for Exchange
   Of Common-Stock Warrants</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 05/16/90</li>
		</ul>
	</div>
	<p class="article-leader">Atrix Laboratories Inc. said it has filed with the
Securities and Exchange Commission for an exchange offer
wherein 646,875 common-stock purchase warrants will be
offered by the company to holders of currently outstanding
common-stock purchase warrants.
   The company, based in Fort Collins, Colo., develops and
produces therapeutic drugs for periodontal disease.</p>
	<div class="article-body"><p>In the exchange, one new warrant will be swapped for each
outstanding warrant. Current warrant holders aren't required
to accept the offer.</p>
<p>Each new warrant to be issued will entitle the holder to
purchase one share of common stock at the price of $2 until
Aug. 15, 1990, the company said.</p>
<p>In over the counter trading yesterday, Atrix closed at
$3.438, bid.</p>
<p></p></div>
</div>
